|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Alfacell Corp., of Bloomfield, N.J., said it will provide its flagship product, Onconase, to the federal severe acute respiratory syndrome testing program to be evaluated against the coronavirus implicated in SARS. Onconase, a ribonuclease cancer product, has demonstrated antiviral activity against RNA viruses similar to SARS, Alfacell said.
o Auxilium Pharmaceuticals Inc., of Norristown, Pa., said its breach of contract suit against PDI Inc., of Upper Saddle River, N.J., has been settled. PDI will make a one-time payment to Auxilium, and delay the launch of its planned testosterone gel product until Jan. 26. Also, the companies terminated existing contractual ...